Key result
Undiagnosed heart failure stage C was associated with a increased 3-year risk of cardiovascular events and all-cause death compared to stage A.
Why the study?
The course of progression and the impact of non-cardiovascular comorbidities on adverse events in early stages of heart failure among elderly high-risk patients were unknown.
Cohort (n=400)
No
In elderly patients with risk factors for heart failure, the risk of adverse cardiovascular events increases with the severity of early HF stages, although non-cardiovascular hospitalizations remain the most common first event.
Answers are grounded in this paper and cite their sources.
Undiagnosed stage C HF signals doubled CV risk in elderly patients; supports staging but leaves open whether detection improves outcomes.
BACKGROUND: Early stages of heart failure (HF) are associated with an increased risk of hospitalization and increased mortality, however the course of progression and the impact of non-cardiovascular comorbidities on adverse events in elderly high-risk patients are unknown. AIM: To examine the risk of future cardiovascular (CV) and non-CV events in early stages of HF in a cohort of elderly patients (age ≥ 60 with ≥ 1 risk factor for HF and without known or clinically suspected HF). METHODS: A total of 400 patients (American Heart Association HF stage A: N = 177; stage B: N = 150; stage C: N = 73) from the Copenhagen Heart Failure Risk Study were identified and followed for the main composite outcome of a HF hospitalization (HFH), ischemic heart disease (IHD), stroke, and all-cause death, recorded within the Danish nationwide registries. Non-CV hospitalization was a secondary outcome. Absolute risk was calculated by the Aalen-Johansen estimator. RESULTS: The median follow-up time was 3.3 years, total number of events were 83, and the 3-year risk (95% confidence interval) of the main outcome was 12.8% (7.8-17.9), 22.8% (16.1-29.6) and 31.8% (21.0-42.6) for patients with stage A, B, and C, respectively. 1.1% (0.0-2.7), 3.4% (1.0-6.3) and 10.0% (2.8-16.3) experienced HFH as their first event, whereas 37.3% (30.2-44.4), 49.7% (41.6-57.8) and 54.8% (43.4-66.2) were admitted for non-CV causes as their first event. CONCLUSION: The risk of HFH, IHD, stroke and all-cause death increased with severity of HF stage, and 10% of patients with undiagnosed HF stage C were admitted for HF within 3 years. However, the risk of non-CV hospitalizations was greater compared to the risk of experiencing HFH.
No takes yet. Share an insight, caveat, or question.
Parveen et al. (2022) conducted a cohort in Early stages of heart failure (n=400). Heart failure stage C vs. Heart failure stage A was evaluated on Composite of first heart failure hospitalization, ischemic heart disease, stroke, and all-cause death (HR 2.01, 95% CI 1.10-3.66). Undiagnosed heart failure stage C was associated with a increased 3-year risk of cardiovascular events and all-cause death compared to stage A.
Synapse has enriched 10 related papers. Consider them for comparative context: